Ohshimo S - Search Results

1

Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis.

Ohshimo S, Bonella F, Grammann N, Starke K, Cui A, Bauer PC, Teschler H, Kohno N, Guzman J, Costabel U. Ohshimo S, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(1):47-53. Sarcoidosis Vasc Diffuse Lung Dis. 2009. PMID: 19960788

2

KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.

Ohshimo S, Yokoyama A, Hattori N, Ishikawa N, Hirasawa Y, Kohno N. Ohshimo S, et al. Biochem Biophys Res Commun. 2005 Dec 30;338(4):1845-52. doi: 10.1016/j.bbrc.2005.10.144. Epub 2005 Nov 2. Biochem Biophys Res Commun. 2005. PMID: 16289035

3

Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma.

Inata J, Hattori N, Yokoyama A, Ohshimo S, Doi M, Ishikawa N, Hamada H, Kohno N. Inata J, et al. Among authors: ohshimo s. Int J Cancer. 2007 Jun 15;120(12):2643-9. doi: 10.1002/ijc.22613. Int J Cancer. 2007. PMID: 17294451

4

[Immunity tests for respiratory diseases--SP-A, SP-D, KL-6].

Kambe M, Ohshimo S, Kohno N. Kambe M, et al. Among authors: ohshimo s. Rinsho Byori. 2007 Apr;55(4):381-7. Rinsho Byori. 2007. PMID: 17511270 Review. Japanese.

5

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Ishikawa N, Hattori N, Yokoyama A, Tanaka S, Nishino R, Yoshioka K, Ohshimo S, Fujitaka K, Ohnishi H, Hamada H, Arihiro K, Kohno N. Ishikawa N, et al. Among authors: ohshimo s. Int J Cancer. 2008 Jun 1;122(11):2612-20. doi: 10.1002/ijc.23411. Int J Cancer. 2008. PMID: 18324627

6

Diagnosis of sarcoidosis.

Costabel U, Ohshimo S, Guzman J. Costabel U, et al. Among authors: ohshimo s. Curr Opin Pulm Med. 2008 Sep;14(5):455-61. doi: 10.1097/MCP.0b013e3283056a61. Curr Opin Pulm Med. 2008. PMID: 18664976 Review.

7

Esophageal sarcoidosis presenting as pseudodiverticulum.

Ohshimo S, Theegarten D, Tötsch M, Moege J, Peitgen K, Guzman J, Costabel U. Ohshimo S, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2008 Sep;25(1):64-7. Sarcoidosis Vasc Diffuse Lung Dis. 2008. PMID: 19070263

8

Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis.

Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U. Ohshimo S, et al. Am J Respir Crit Care Med. 2009 Jun 1;179(11):1043-7. doi: 10.1164/rccm.200808-1313OC. Epub 2009 Feb 26. Am J Respir Crit Care Med. 2009. PMID: 19246718

9

Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease.

Cui A, Anhenn O, Theegarten D, Ohshimo S, Bonella F, Sixt SU, Peters J, Sarria R, Guzman J, Costabel U. Cui A, et al. Among authors: ohshimo s. Respiration. 2010;80(5):372-8. doi: 10.1159/000245332. Epub 2009 Oct 6. Respiration. 2010. PMID: 19816001 Free article.

10

Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET.

Costabel U, Bonella F, Ohshimo S, Guzman J. Costabel U, et al. Among authors: ohshimo s. Semin Respir Crit Care Med. 2010 Aug;31(4):404-8. doi: 10.1055/s-0030-1262207. Epub 2010 Jul 27. Semin Respir Crit Care Med. 2010. PMID: 20665390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters